Sanofi has had a “positive and constructive” meeting with the US Food and Drug Administration to get its switch of erection dysfunction drug Cialis back on track.
Sanofi Feeling Positive On Cialis Switch Progression As Q2 Sales Rise
As Sanofi reports Consumer Healthcare second-quarter sales up by 9%, the company is hopeful it can progress its plan to switch erectile dysfunction drug Cialis in the US following a constructive meeting with the FDA.